GOSS (Gossamer Bio Inc) Sof foyda

GOSS (Gossamer Bio) - kompaniyaning tovar belgisi

GURU.Markets platformasida Gossamer Bio, Inc. (GOSS) kompaniyasining bozor qiymati dinamikasi -0.13 darajasida bo'lib, bu sog'liqni saqlash giganti tomonidan o'pka tomir patologiyalari terapiyasi uchun yangi standartlarni joriy etish yo'lidagi intilishlarini ko'rsatadi. Biznes murakkab kasalliklarni o'rganish uchun tibbiyot markazlari bilan hamkorlikka tayanadi; biroq, tez sur'atdagi tadqiqot va ishlanmalar (R&D) xarajatlari hamda seralutinibning 3-fazali sinovlari natijalari bo'yicha noaniqliklar kompaniyaning moliyaviy barqarorligiga sezilarli bosim o'tkazmoqda.

GOSS (Gossamer Bio, Inc.) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

Gossamer Bio (GOSS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Gossamer Bio Corp.|GOSS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Gossamer Bio Corp.|GOSS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Gossamer Bio|GOSS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi gossamerbio.com|GOSS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Gossamer Bio, Inc.|GOSS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Gossamer Bio Inc|GOSS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Gossamer Bio Corp.|GOSS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Gossamer Bio|Shoshilinch likvidlik gossamerbio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
GOSS - Sof foyda
Kompaniyaning jamlanma tahlili:Gossamer Bio, Inc.
Gossamer Corp asosiy tovari

Gossamer Bio, Inc. (GOSS) foydasi barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyingi yakuniy moliyaviy natijani qayd etadi. Mutaxassislar ushbu ko'rsatkichdan biznesning barqarorligini va uning o'z-o'zini moliyalashtirish qobiliyatini baholash uchun foydalanadilar. Tashkilotning sof foydasini tahlil qilish orqali investor bozor talabi va kapital risklari o'rtasidagi muvozanat nuqtasini aniqlaydi. Gossamer Bio, Inc. (GOSS) uchun salbiy tendentsiya klinik biotexnologiyalarning o'ziga xos tabiatini aks ettiradi. Foydaning yo'qligi dori vositalarini sinovdan o'tkazish ishlari yakunlanmaguncha kompaniyaning tashqi investitsiyalarga bog'liqligini ta'kidlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Yillik sof foyda Pharming Corp (PHAR)|Nektar Therapeutics (NKTR) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi upstreambio.com (UPB)|Kompaniyaning sof foydasi Zenas Biopharma|Immunome Inc (IMNM) - Sof moliyaviy natija|Kompaniyaning sof foydasi KalVista Pharmaceuticals Inc (KALV)|Sof moliyaviy natija Septerna Pharma|Sof foyda PVLA (Pieris Pharmaceuticals)|Sof foyda savarapharma.com SVRA|RIGL - Kompaniyaning sof foydasi|AnaptysBio Inc (ANAB) - Sof daromad|ATXS: Sof foyda|Kompaniyaning sof daromadi enGene Corp (ENGN)|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|JBIO: Yakuniy foyda|Sof daromad ACRS (Aclaris Therapeutics, Inc.)|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Cabaletta Bio Inc - Kompaniyaning sof foydasi|Ventyx Biosciences - Sof foyda|Sof moliyaviy natija theratech.com THTX|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Eledon Pharmaceuticals Inc. (ELDN)|Sof daromad AGEN|CLYM: Yakuniy foyda|Sof foyda ZURA|Sof moliyaviy natija atyrpharma.com|Kompaniyaning sof foydasi Adagene Inc. ADAG|IMA: Kompaniya foydasi|Shattuck Therapeutics - Sof foyda|Equillium, Inc. (EQ) - Sof daromad|CNTB (connectbiopharm.com) - Sof daromad|IMUX - Sof moliyaviy natija|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|IFRX - Yillik sof foyda|Kompaniyaning sof foydasi X4 Pharma (XFOR)|ACET - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Celularity CELU|Sof moliyaviy natija inmunebio.com (INMB)|BRNS - Kompaniyaning sof foydasi|Sof moliyaviy natija Kezar Life Sciences Inc. KZR|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda AKTX (Akari Therapeutics, Plc)|ENLV (Enlivex Therapeutics Ltd) - Sof foyda|QTTB: Yakuniy foyda|Sof foyda GOVX|Sof foyda Edesa Biotech Inc (EDSA)|Kompaniyaning sof foydasi iBio Corp IBIO|Yakuniy foyda CARM|XTLB - Kompaniyaning sof foydasi|Bolt Biotherapeutics (BOLT) - Sof daromad|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Sof daromad AIM|ADTX: Yakuniy foyda|Sof foyda GRI|Sof moliyaviy natija xortx.com|Kompaniyaning sof foydasi Vyome Holdings HIND|REVB - Sof daromad|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI (calcimedica.com) - Sof daromad|Affimed N.V. (AFMD) - Sof foyda|Kompaniyaning sof foydasi Allakos Inc|Kompaniya foydasi HOOK (HOOKIPA)|Sof foyda IGMS|ITOS - Kompaniyaning sof daromadi|Sof foyda OCEA (Ocean Biomedical, Inc.)|Yillik sof foyda tcbiopharm.com|THRD - Kompaniyaning sof foydasi